rs2269475

This is a upstream gene variant variant in the AIF1 gene.

Research that mentions this SNP (3)

A genetic association study in the Gambia using tagging polymorphisms in the major histocompatibility complex class III region implicates a HLA-B associated transcript 2 polymorphism in severe malaria susceptibility
AssociationN=2,162Mahamadou Diakite et al.(2009)· Human Genetics

A case-control association study of 2162 Gambian individuals identified a BAT2 polymorphism (rs1046089) significantly associated with severe malaria (G vs A OR=0.73, P<10⁻⁶ for allelic test; recessive model GG vs GA/AA OR=0.48, P<10⁻⁶). Haplotype analysis confirmed BAT2-associated variants conferred ~40% reduced risk. Secondary findings included AIF1 (rs2259571, OR=0.57, P=0.004) and TNF-238 (rs361525, OR=1.33, P=0.04) associations, though only BAT2 remained significant after Bonferroni correction.

Traits studied:Cerebral malariaSevere malariaSevere malarial anaemia
Type 2 diabetes susceptibility loci in the Ashkenazi Jewish population
AssociationN=1,312Michal Bronstein et al.(2008)· Human Genetics

This study characterized an Ashkenazi Jewish (AJ) population-specific genetic signature using genome-wide SNP data from 1,312 AJ individuals. Using ADMIXTURE and principal components analysis, the authors identified allelic patterns that differentiate AJ from European and Middle Eastern populations. Gene Ontology enrichment analysis of the AJ-specific genetic signature revealed enrichment in genes involved in transepithelial chloride transport (including CFTR with rs213950 showing V158M variant) and equilibrioception (PCDH15, CLRN1), implicating these pathways in the elevated prevalence of cystic fibrosis and Usher syndrome in Ashkenazi Jews. The study also identified disease-relevant alleles including MTHFR C677T (rs1801133), SH2B3 rs3184504 associated with type 1 diabetes/celiac disease, and MC1R rs1805005, and provided a validated set of 103 ancestry informative markers (AIMs) for population stratification correction.

Traits studied:Alzheimer's diseaseAncestry informative markersAshkenazi Jewish population structureAutoimmune diseasesCeliac diseaseCrohn's diseaseCystic fibrosisMelanomaMetabolic disordersMultiple sclerosisRheumatoid arthritisType 1 diabetesType 2 diabetesUsher syndrome
Association of the PTPN22 R620W polymorphism with anti–topoisomerase I– and anticentromere antibody–positive systemic sclerosis
ReviewPravitt Gourh et al.(2006)· Arthritis &amp; Rheumatism

This review examines genetic factors in systemic sclerosis (scleroderma), describing multiple genetic loci and candidate genes associated with disease susceptibility. The PTPN22 R620W polymorphism shows strong association with SSc subgroups (OR=2.36 for ATA-positive patients, OR=1.71 for ACA-positive patients). The paper discusses evidence from genome-wide studies and candidate gene approaches, highlighting HLA region polymorphisms, TNF promoter variants, AIF1 rs2269475, and the importance of Fli1 dysregulation in SSc pathogenesis.

Traits studied:Rheumatoid arthritisSclerodermaSystemic lupus erythematosusSystemic sclerosis

About AIF1

This gene encodes a protein that binds actin and calcium. This gene is induced by cytokines and interferon and may promote macrophage activation and growth of vascular smooth muscle cells and T-lymphocytes. Polymorphisms in this gene may be associated with systemic sclerosis. Alternative splicing results in multiple transcript variants, but the full-length and coding nature of some of these variants is not certain. [provided by RefSeq, Jan 2016]

View all AIF1 variants →

Gene information from NCBI Gene. Variant classifications from ClinVar.

Community Wiki

No community notes yet for this variant. Sign in to start one.

Comments

Sign in to join the discussion.

Loading comments…